The Baldwin Group agreed on Monday to go private in an all cash deal that values the insurance brokerage at roughly $7.7 billion, with shareholders receiving $32.50 a share from an entity formed by Sequence Holdings and DFO Management, the family investment office of Dell Technologies founder Michael Dell. Coverage of the deal has led with the price and with the roughly 88 percent premium. Read the three principal quotes in Baldwin’s own announcement instead, and a different transaction appears: not one of them is about insurance.
Chief executive Trevor Baldwin describes the point of the deal as securing “long duration capital and frontier AI execution to invest and move at the pace this moment demands.” Sequence co-founder Michael J. Lee says he looks forward to working with the team “to rebuild workflows, products, and services around what is now possible with technology.” Michael Dell talks about permanent capital and the absence of a fixed exit clock. Nobody mentions clients, carriers, commission economics or distribution. This is an automation thesis that happens to be wearing a brokerage.
The Multiple Only Works if the Headcount Falls
That framing is the only way the arithmetic holds together. The $7.7 billion enterprise value represents approximately 20 times Baldwin’s trailing twelve month adjusted EBITDA of roughly $396 million. Twenty times is a full price for an insurance brokerage, a business whose costs are overwhelmingly people and whose growth is overwhelmingly relationships.
Buyers do not pay twenty times for a mature people business because they expect the people to get more productive on their own. They pay it because they believe they can take a structural amount of cost out, or because they believe the asset compounds for long enough that the entry multiple stops mattering. Dell’s reference to permanent capital argues for the second. Lee’s reference to rebuilding workflows argues for the first. The deal is underwritten on both.
Two details in the structure are worth separating from the headline, because both are routinely misread:
- The $7.7 billion is enterprise value, not the cheque. It breaks into roughly $4.6 billion of equity purchase price and approximately $3.1 billion of net debt assumed or refinanced. Forty percent of the number in the headline is borrowed.
- The 88 percent premium is measured against the unaffected closing price on June 17, the day before reports of a possible deal surfaced. The stock re-rated on that leak. Anyone reading 88 percent as Monday’s uplift is reading a three month old price.
Neither point makes this a bad deal. Both make it a smaller and more leveraged one than the round number suggests, in a rate environment where the ten year Treasury touched 5 percent the same day the deal was announced. That financing was arranged into a very different curve than the one it now has to live with.
The Thing That Can Actually Go Wrong Is Not Technological
Insurance brokerage is the rare business where the asset can resign. Producers own their books in every way that matters short of the legal one, and the history of leveraged brokerage roll ups is substantially a history of senior producers leaving for a competitor and taking renewals with them once the equity story changes.
The buyers clearly know this, which is why eligible employees are being offered the chance to roll holdings into the private company and retain what the announcement calls a significant minority equity stake. That is the correct structural answer, and it is a genuine point in the deal’s favour. It is also the part that is in tension with the automation thesis. You cannot simultaneously tell producers that their equity is the retention mechanism and rebuild the workflows those producers sit inside, without being extremely specific about which roles the technology replaces and which it augments. Nothing announced on Monday is specific about that.
Our View
We think this deal is defensible and we think the reporting on it has been incurious. Twenty times EBITDA for a brokerage is only justified by the operating thesis the buyers stated in plain language and almost nobody quoted, and they deserve credit for stating it plainly rather than hiding behind the usual language about scale and efficiencies. Michael Dell’s family office buying a distribution business to rebuild it with software is a coherent position for an investor whose operating company guided its AI server line lower this quarter because it cannot buy enough memory. If the hardware side of the AI trade is supply constrained, the applied side is where the return is.
What should happen next is a disclosure the buyers have no obligation to make and should make anyway. Take private transactions of this kind are consistently sold to employees as investment and delivered as cost reduction, and the gap between those two stories is where trust goes. Baldwin has until the expected close in the first quarter of 2027 to tell its producers which it is.
The public test is simple enough to state now. If this works, Baldwin’s organic revenue growth holds through 2027 while its cost base falls, and the twenty times looks cheap in hindsight. If it does not, the tell will be visible long before the financials are: a run of senior producer departures in the first two quarters after close. Watch the people, not the technology. In this business they have always been the same number.